Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Return on Sales (2016 - 2025)

Historic Return on Sales for Zevra Therapeutics (ZVRA) over the last 9 years, with Q3 2025 value amounting to 0.02%.

  • Zevra Therapeutics' Return on Sales rose 89600.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year increase of 40800.0%. This contributed to the annual value of 4.47% for FY2024, which is 27900.0% down from last year.
  • Zevra Therapeutics' Return on Sales amounted to 0.02% in Q3 2025, which was up 89600.0% from 2.88% recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Return on Sales ranged from a high of 3.59% in Q4 2022 and a low of 19.62% during Q2 2022
  • Over the past 5 years, Zevra Therapeutics' median Return on Sales value was 1.05% (recorded in 2021), while the average stood at 2.51%.
  • Per our database at Business Quant, Zevra Therapeutics' Return on Sales crashed by -201400bps in 2022 and then soared by 193200bps in 2023.
  • Quarter analysis of 5 years shows Zevra Therapeutics' Return on Sales stood at 1.05% in 2021, then skyrocketed by 443bps to 3.59% in 2022, then plummeted by -143bps to 1.54% in 2023, then crashed by -93bps to 2.98% in 2024, then skyrocketed by 99bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, 2.88% for Q2 2025, and 0.15% during Q1 2025.